PubMed Health⌕ Search

Biomedical subjects

S D Shafran

Publications and source records attributed to S D Shafran.

40 records · Page 3Linked to original sources

Appropriateness of metronidazole use in a teaching hospital.

The appropriateness of metronidazole use at a teaching hospital was determined by a retrospective audit. All orders for metronidazole received by the hospital pharmacy from December 26, 1986, to May 15, 1987, were identified, and the charts of the patients involved were reviewed to determine whether the drug's use was appropriate or inappropriate according to pre-established guidelines for indication, dose, dosage interval, and duration of therapy or prophylaxis. The oral route of administration was considered appropriate for patients who were taking other oral medications or who were on a diet of at least clear fluids. The acquisition cost of metronidazole from January to June 1987 was used to determine the potential cost avoidance that would result if (1) all types of inappropriate use were corrected, or (2) only the inappropriate route of administration were corrected. A total of 104 courses of therapy in 98 patients were evaluated, of which 76 were therapeutic and 28 were prophylactic. Of the 104 courses, 62% were found to be inappropriate by at least one of the criteria for appropriate use, excluding route of administration. Of the 893 doses of metronidazole administered by the i.v. route, 424 (47%) could have been given orally. A drug cost analysis revealed that $3954 (48% of the total hospital expenditure for metronidazole) could have been saved by substituting oral metronidazole for i.v. metronidazole when possible. If all criteria for appropriate use of metronidazole had been followed, $5977 could have been saved, which represents 71% of the current hospital expenditure for metronidazole.(ABSTRACT TRUNCATED AT 250 WORDS)

Costs and Cost Analysis↗

A syndromic approach to common parasitic diseases.

Standard textbooks discuss parasitic disease according to specific organisms. In contrast, patients with parasitic infections present to physicians with a variety of clinical manifestations that may involve any of several organ systems and that often mimic nonparasitic diseases. A syndromic approach to the clinical situation may help the physician in considering the most important parasitic agents. Many parasitic infections can be acquired in temperate climates. While often considered tropical or exotic, other parasitic diseases are now seen more frequently in developed countries because of immigration and increased world travel. In this review the clinical syndromes associated with common parasitic diseases in North America are discussed, with an emphasis on risk factors and diagnosis of specific infections.

Cholangitis↗

In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.

The in vitro activities of Sch 34343, a new penem antibiotic, and cefbuperazone, a new cephamycin antibiotic, were determined against 459 clinical anaerobic bacterial isolates and compared with the activities of imipenem and cefoxitin, respectively, by an agar dilution method. Both penems showed potent and similar activity against all anaerobic bacteria tested, particularly Peptococcus spp., Bacteroides fragilis, and Clostridium perfringens. All organisms except a single strain of Fusobacterium necrogenes were inhibited by an 8 micrograms/ml concentration of either Sch 34343 or imipenem. Overall, gram-positive bacilli, particularly Lactobacillus species, Clostridium difficile, and Bifidobacterium and Actinomyces species, were relatively more resistant to either penem than other genera of anaerobic bacteria tested. Cefbuperazone demonstrated only modest activity against a wide spectrum of anaerobic bacteria. It had excellent and selective activity against B. fragilis and Bacteroides vulgatus but was highly inactive against Bacteroides distasonis and Bacteroides thetaiotaomicron within the B. fragilis group. Both cephamycins showed virtually no activity against C. difficile and Lactobacillus spp. Although cefbuperazone was more active against Bifidobacterium spp., it had less activity against Fusobacterium spp., Eubacterium spp., and all Bacteroides spp. other than B. fragilis and B. vulgatus.

Anti-Bacterial Agents↗

Prevention and treatment of disseminated Mycobacterium avium complex infection in human immunodeficiency virus-infected individuals.

Disseminated Mycobacterium avium complex (DMAC) infection is a common complication of advanced HIV disease, and is an independent predictor of mortality. The clinical features of DMAC infection are fever, weight loss, abdominal pain, anemia, elevated serum alkaline phosphatase, and elevated serum lactate dehydrogenase. The diagnosis is made by blood cultures; clinical diagnosis is unreliable. Chemoprophylaxis of DMAC infection with azithromycin is recommended when the CD4 lymphocyte count is below 50 cells/mm3. Established DMAC infection is treated with clarithromycin plus ethambutol, unless the isolate is macrolide-resistant, in which case the optimal therapy is uncertain. Highly active antiretroviral therapy is important in both prevention and treatment of DMAC infection.

AIDS-Related Opportunistic Infections↗